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between upper and lower extremity fractures 
with snow/ice accumulation, but not rain/
melted snow. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.054
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Background: The diagnosis of 
myelodysplastic syndromes (MDS) and 
myelodysplastic/myeloproliferative 






exceptions (e.g. SF3B1 mutations), somatic 
mutations have not been incorporated as 
diagnostic criteria. In this study we analyzed 
the utility of mutational analysis with a 
targeted 54-gene or 40-gene next generation 
sequencing (NGS) panel in diagnosis of MDS 
and MDS/MPN.
Methods: The clinicopathologic data and 
NGS results of patients with unexplained 
cytopenia with or without cytosis who 
underwent a bone marrow (BM) biopsy and 
had sequencing with either a 54 gene Trusight 
Myeloid or a 40 gene Oncomine Myeloid 
NGS Assay performed at our institution from 
2017 to 2019. Morphologic diagnosis of BM 
""			
was considered gold standard.
Results: #	$	%&
including 25 low-grade MDS (peripheral 
blood blasts <1% and BM blasts <5%), 16 
high-grade MDS (peripheral blood blasts 
2-19% and BM blasts 5-19%), 5 therapy-
related MDS, 14 MDS/MPN, and 14 
morphological negative ones. Of 74 patients, 
158 somatic mutations involving 37 genes 
were detected and had variant allele frequency 
(VAF) ranging from 3% to 99%. 62% 
(23/37) genes showed recurrent mutations 
and 38% (14/37) genes had one mutation 
each. The most common mutated genes were 
TET2, ASXL1, RUNX1, SF3B1 and TP53. 
Morphological negative, low-grade MDS, 
high-grade MDS, therapy-related MDS and 
MDS/MPN showed an average number of 
somatic mutations with a mean VAF: 1.5/20%, 
2/37%, 3.1/38%, 2/33% and 4.8/41%, 
respectively. Mutations in TP53, RUNX1, or 
ASXL1 were associated with high-grade and 
therapy-related MDS (p=0.004), while SF3B1 
mutations were associated with low-grade 
MDS (p=0.001). In 60 of 74 patients with a 
diagnosis of MDS or MDS/MPN, 32 showed 
abnormal cytogenetics and 28 showed normal 
cytogenetics. One or more mutations were 
detected in 25 of 28 (89%) MDS or MDS/
MPN patients with normal cytogenetics. The 
*&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value (PPV) and negative predictive value 
(NPV) of mutations for MDS and MDS/ 
MPN with different cutoffs are summarized 
in Table 1.
Conclusion: A myeloid mutational panel 
provides additional evidence of clonality 
besides cytogenetics/FISH studies in 
diagnosis of cytopenia with or without cytosis, 
	+;	%+>?#

predicts MDS and MDS/MPN with a PPV of 
100%. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.055
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Background: Limited data exists on the 
optimal revascularization strategy for patients 
with left main coronary artery disease 
(LMCAD) and chronic kidney disease (CKD). 
We conducted this updated meta-analysis 
to compare the outcomes of coronary artery 
bypass graft (CABG) versus percutaneous 
coronary intervention (PCI) in this population.
Methods: Multiple electronic databases 
were searched for studies comparing CABG 
and PCI in CKD patients undergoing 




ml/min/1.73 m2. Primary outcome of interest 
was long term major adverse cardiovascular 
and cerebral events (MACCE) which 
was a composite of cardiovascular death, 
myocardial infarction (MI), stroke and repeat 
revascularization. Other outcomes of interest 
Table 1.










mutations, or abnormal 
cytogenetics/FISH
Sensitivity     83%
	
	
  93% 93% 100% 
PPV 88% 98% 98% 100% 
NPV   34%  
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were all cause mortality, MI, stroke and 
repeat revascularization. Odds ratios (OR) 
	`{>Z*	|ZQ%
calculated. The analysis was performed using 
DerSimonian and Laird random effect model.
Results: In total, six studies (four 
observational and two randomized controlled 
trials) met our inclusion criteria with a total 
of 2198 patients (CABG: 1050, PCI: 1148). 
Patients undergoing CABG had a higher 
incidence of multivessel disease (74.7% vs 
65.7%, p = 0.01) At a mean follow-up of 




compared to PCI group (OR = 0.70, 95% CI = 
0.57 – 0.87; p = 0.001) (Figure 1). The odds 
of MI or repeat revascularization were lower 




was seen in all-cause mortality.
Conclusion: Our analysis shows that CABG 
is associated with better long-term outcomes 
as compared to PCI in LMCAD patients with 
CKD. 
https://doi.org/10.32873/unmc.dc.gmerj.2.1.056
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Background: Transradial access (TRA) 
is now increasingly used for percutaneous 
coronary intervention (PCI) in ST Elevation 
Myocardial Infarction (STEMI) vis-à-vis 
Transfemoral access (TFA). We conducted a 
meta-analysis of randomized controlled trials 
*	;	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of the two approaches in STEMI-PCI.
Methods: PubMed, Cochrane, Embase 
databases and major national conference 
proceedings were systematically searched 




outcomes studied were all-cause mortality, 
major adverse cardiovascular events (MACE), 
myocardial infarction (MI) and stroke. Safety 
outcomes included major bleeding and 
vascular complications. Odds ratios (OR) 
	`{>Z*	|ZQ%
calculated. The analysis was performed using 
DerSimonian and Laird random effects model.
Results: In total, 17 trials met our inclusion 
criteria with a total of 12018 patients 










Figure 1. Forest plots comparing outcomes between CABG and PCI for LMCAD revascularization in CKD patients.
